Last Updated: 18/06/2024

Study on the mechanism of the transcription factor ApiAP2 in the resistance of Plasmodium falciparum to Artemisinin

Objectives

This project will explore the mechanism of the transcription factor ApiAP2 in the resistance of Plasmodium falciparum to Artemisinin.

Principal Institution

Jiangsu Institute of Parasitic Diseases (JIPD), China

Principal Investigators / Focal Persons

Jun Cao

Themes

Drug Resistance

Date

Jan 2020 — Dec 2023

Total Project Funding

$84,350

Funding Details
National Natural Science Foundation of China (NSFC), China

Grant ID: 81971967
CNY 550,000
Country / Project Site(s)

China

SHARE

Related Resources

Publications (GenMoz)
Publications (GenMoz)
Multiple first-line therapies as part of the response to antimalarial drug resistance
Multiple first-line therapies as part of the response to antimalarial drug resistance
ASTMH 2017, James Heaton: “Speeding up malaria elimination; a cluster randomized controlled trial of mass drug administration in Southeast Myanmar, an area with artemisinin resistance”
ASTMH 2017, James Heaton: “Speeding up malaria elimination; a cluster randomized controlled trial of mass drug administration in Southeast Myanmar, an area with artemisinin resistance”

Related Projects

Jan 2017 —
Dec 2019
Study on the mechanism of Artemisinin resistance of Plasmodium falciparum K13 gene M579I
Oct 2019 —
Mar 2023
Understanding the mechanism of the African-type Artemisinin resistance of Plasmodium falciparum
Jan 2020 —
Dec 2023
Study on the mechanism of Plasmodium falciparum transcription factor TFIIIC regulating gene expression through genome conformation
SHARE